Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Treatment Options in Neurology|June 16, 2009
Treatment of spinal cord tumorsBrian Vaillant, Monica LoghinCurrent Treatment Options in Neurology|June 22, 2005
The Treatment of Malignant GliomasMark R Gilbert, Monica LoghinCurrent Treatment Options in Neurology|December 14, 2005
Headache related to brain tumorsMonica Loghin, Victor A LevinInternational Journal of Radiation Oncology, Biology, Physics|April 20, 2010
Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous systemVictor A Levin, Luc Bidaut, Ping Hou, et al.Neuro-Oncology Practice|May 18, 2018
Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105Michelle J Naughton, L Douglas Case, Ann Peiffer, et al.Advances in Radiation Oncology|January 27, 2025
Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid TumorsKeng Lam, Lewis F Nasr, Clark R Andersen, et al.Cancer|November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic gliomaPierre Giglio, Megha Dhamne, Kenneth R Hess, et al.Neuro-Oncology Advances|September 21, 2022
Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysisRituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, et al.Nature Communications|April 27, 2025
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trialShiao-Pei Weathers, Xiqi Li, Haifeng Zhu, et al.Neuro-Oncology|November 23, 2019
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophagesJohn de Groot, Marta Penas-Prado, Kristin Alfaro-Munoz, et al.Pageof 2